TABLE 3.
Clinical outcome according to diagnosis
| Indication | n | Weaned or bridged to AB5000* or transplant | Expired on device | Discharged |
|---|---|---|---|---|
| Acute fulminant myocarditis | 4 | 3 (75) | 1 (25) | 3 (75) |
| Postpartum CMP | 2 | 2 (100) | 0 (0) | 0 (0) |
| EFE | 1 | 0 (0) | 1 (100) | 0 (0) |
| S/P CABG | 3 | 1 (33) | 2 (66) | 0 (0) |
| S/P LVAD | 2 | 1 (50) | 1 (50) | 0 (0) |
| S/P OHT | 6 | 3 (50) | 3 (50) | 2 (33) |
Data presented as n (%) unless otherwise indicated.
*
ABIOMED Inc, USA. CABG Coronary artery bypass graft; CMP Cardiomyopathy; EFE Endocardial fibroelastosis; LVAD Left ventricular assist device; OHT Orthotopic heart transplant; S/P Status post